Value of insulin-like growth factor system markers in the assessment of growth hormone status.

Value of insulin-like growth factor system markers in the assessment of growth hormone status. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Value of insulin-like growth factor system markers in the assessment of growth hormone status. Abstract Text:

David R Clemmons,

Insulin-like growth factor-I (IGF-I) has been measured extensively in a variety of clinical settings. Total IGF-I frequently is used to assess the clinical impact of disorders of GH secretion and to monitor patients' response to therapy. It does not have sufficient precision to be used as a stand-alone test in the diagnosis of GH deficiency. Free IGF-I, IGF binding protein-3, or acid-labile subunit may provide useful information regarding GH secretion in specific conditions but are not superior to IGF-I for making the diagnosis of GH deficiency or acromegaly.

Value of insulin-like growth factor system markers in the assessment of growth hormone status. Publishing Authors By Initials

DR Clemmons,

For similar peptides: intercellular signaling peptides and proteins: somatomedins research abstracts see: peptides: intercellular signaling peptides and proteins: somatomedins research

PUBMED ID PMID:

MEDLINE DATE:

Value of insulin-like growth factor system markers in the assessment of growth hormone status. Journal Published:

PUBLICATION TYPE: Review

Journal: Endocrinology and metabolism clinics of North Amer

VOLUME: 36

Page Numbers: 109-29

Journal Abbreviation: Endocrinol. Metab. Clin. North

ISSN: 0889-8529

DAY: 3

MONTH: Mar

YEAR: 2007

Value of insulin-like growth factor system markers in the assessment of growth hormone status. Information

Number of References: 136

LANGUAGE: eng

NlmUniqueID: 8800104

Value of insulin-like growth factor system markers in the assessment of growth hormone status. Keywords Mesh Terms:

KEYWORDS: Somatomedins

MESH TERMS: metabolism

Chemical & Substance for Abstract: Value of insulin-like growth factor system markers in the assessment of growth hormone status. Information

Substance Name: Growth Hormone

Registry Number: 9002-72-6

Grant and Affiliation Information for Value of insulin-like growth factor system markers in the assessment of growth hormone status.

AFFILIATION: Division of Endocrinology, University of North Carolina School of Medicine, University of North Carolina, CB #7170, 8024 Burnett-Womack, Chapel Hill, NC 27599, USA. endo@med.unc.edu

Country: United States

AGENCY: United States NIA

GRANT: AG02331

ACRONYM: AG

MEDLINETA: Endocrinol Metab Clin North Am

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Value of insulin-like growth factor system markers in the assessment of growth hormone status Related Publications

• Bilateral fractures of the head of the humerus; due to electric shock.
• Detection of oligoclonal bands in cerebrospinal fluid from German Shepherd dogs with degenerative myelopathy by isoelectric focusing and immunofixation.
• Expression of the human beta3 integrin subunit in mouse smooth muscle cells enhances IGF-I-stimulated signaling and proliferation.
• Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I.
• Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I.
• IGF-I assays: current assay methodologies and their limitations.
• Insulin-like Growth Factor-I Stimulates Shc-dependent Phosphatidylinositol 3-Kinase Activation via Grb2-associated p85 in Vascular Smooth Muscle Cells.
• Insulinlike growth factor binding proteins.
• Integrin-associated protein association with SRC homology 2 domain containing tyrosine phosphatase substrate 1 regulates igf-I signaling in vivo.
• Long-acting forms of growth hormone-releasing hormone and growth hormone: effects in normal volunteers and adults with growth hormone deficiency.
• Measurement of myelin basic protein in the cerebrospinal fluid of dogs with degenerative myelopathy.
• Modulation of integrin antagonist signaling by ligand binding of the heparin-binding domain of vitronectin to the alphaVbeta3 integrin.
• Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.
• Protease-resistant insulin-like growth factor (IGF)-binding protein-4 inhibits IGF-I actions and neointimal expansion in a porcine model of neointimal hyperplasia.
• Regulatory Actions of Insulin-like Growth Factor-binding Proteins.
• Sports Injuries among U.S. Army Soldiers Deployed for Operation Iraqi Freedom: 2182: Board #95 June 1 8:00 AM -9:30 AM.
• The surgical treatment of fractures of the lateral tibial condyle.
• Value of insulin-like growth factor system markers in the assessment of growth hormone status.
• p66shc Negatively Regulates Insulin-Like Growth Factor I Signal Transduction via Inhibition of p52shc Binding to Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Substrate-1 Leading to Impaired Growth Factor Receptor-Bound Protein-2 Membrane